Adherium Limited
- Jurisdiction
New Zealand - ISIN
AU000000ADR1 (ADR.AX )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Fundamental strength relative to industry (Mohanram G-Value)
-
1
/ 7
Profile
Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, North America, and Asia. Read full profile
Stock price
Fundamentals
- Net revenue
€1.85M - Gross margin
25.0% - EBIT
-€13.00M - EBIT margin
-702.5% - Net income
-€11.17M - Net margin
-604.0%
Statement period: - (published )
Dividends
No dividend payouts